Weakness in the HST segment, escalating selling, general and administrative expenses and unfavorable movements in foreign currencies are major challenges for IDEX.

Higher raw material, energy and freight costs and the impact of the supply chain disruptions will weigh on Sonoco’s results in the near term. Ongoing destocking add to the concerns.

High labor costs arising out of the deal with the teamsters and the weak demand-induced volume woes are hurting the UPS stock significantly.

Molson Coors continues to witness inflationary pressures with respect to materials and manufacturing expenses.

Persistent inflationary pressures pose a threat to Omnicell’s operations. Weak hospital spending trends and tough competition are additional headwinds. 

Choppy office market, geographic concentration of assets and competition from developers and operators are key concerns for Vornado. High interest rates are likely to add to its woes.

Elevated medical cost trends impede CVS Health's profitability. A highly competitive market and pressure on margins remain a concern.

Rising debt, concentrated customer base and high capital spending might hurt Magna's performance.

Considering macroeconomic challenges like softness in overall prestige beauty in mainland China and geopolitical volatility in certain regions, management lowered its fiscal 2024 top-line view.

Nevro’s dependence on third-party payors and regulatory requirements are worrying. Stiff competitive forces and macroeconomic uncertainties prevail.